MD Anderson2nd Annual Sawyer International Pancreatobiliary Symposium December 1-2, 2017

MD Anderson, Dan L. Duncan BuildingConference Center, Floor 81155 Pressler StreetHouston, Texas

Program ChairsJeffrey H. Lee, MD, MPHManoop Bhutani, MDBoris Blechacz, MD, PhD

Goal

The goal of this symposium is to understand how cholangiocarcinoma and other biliary pancreatic cancers can be best managed by clinicians in this area. During this international symposium, the experts from various regions of the world will share the findings of their research, clinical experience, and recommendations regarding these cancers. We expect this symposium will change the practice of the attendees who will acquire the state-of-the-art clinical information about the diseases, thus improving the overall survival of patients with the diseases.

Educational Objectives

After attending the conference, participants should be able to

• Apply advances in imaging, endoscopic techniques, and cytopathology in the treatment of biliary pancreatic diseases (Knowledge, Competence, Performance);

• Utilize therapeutic endoscopy and interventional radiology, while assessing the strengths and limitations of different approaches, in managing biliary obstruction (Knowledge, Competence, Performance, Patient Outcomes);

• Implement updates on surgical approach for resection, transplant, and palliative surgery into practice (Knowledge, Competence, Performance);

• Incorporate the best available chemotherapy regimen and/or radiation treatment (Knowledge, Competence, Performance).

Educational Methods

Lectures – Panel Discussions – Case Studies – Question and Answer Sessions

Target Audience

This symposium should be of value to gastroenterologists, medical oncologists, surgeons, interventional radiologists, and internists.

Evaluation

A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/ Credit Designation

PHYSICIANS

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live

activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants as they depart the symposium. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.

Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

Physicians Payments – Sunshine Act

MD Anderson complies with the Physicians Payments Sunshine Act as part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfer of value provided to any covered recipient under the ACA.

MD Anderson Program Planning Committee

PROGRAM CHAIRS

Jeffrey H. Lee, MD, MPHProfessorGastroenterology, Hepatology & Nutrition

Manoop Bhutani, MDProfessorGastroenterology, Hepatology & Nutrition

Boris Blechacz, MD, PhDAssistant ProfessorGastroenterology, Hepatology & Nutrition

COMMITTEE MEMBERS

Milind Javle, MDProfessorGI Medical Oncology

Selvi Thirumurthi, MDAssociate ProfessorGastroenterology, Hepatology & Nutrition

Brian Weston, MDAssociate ProfessorGastroenterology, Hepatology & Nutrition

Carol CoxProgram CoordinatorGastroenterology, Hepatology & Nutrition

Constance C. Tierney, CMPManagerCME/Conference Management

We appreciate scholarships from Dr. Raju – John Stroehlein Distinguished Professorship and Charles Butt and H-E-B Gastrointestinal Cancer Prevention, Research, and Education Program for trainees, endoscopy nurses and technicians, MLPs and endoscopy research teams to benefit from this program.

H-E-B Gastrointestinal Cancer Prevention, Research, and Education Program is an endowment to The University of Texas MD Anderson Cancer Center.

If interested in applying for this scholarship, which covers registration to the symposium, please check the box on the registration form.

Program

Friday, December 1, 2017

5:00 p.m. Registration/Dinner

5:45 Opening Remarks Manoop Bhutani, MD Boris Blechacz, MD, PhD

5:50 Keynote Address Stacie Lindsey President of Cholangiocarcinoma Foundation

CHOLANGIOCARCINOMA IModerators: Gottumukkala S. Raju, MD; Jeffrey H. Lee, MD

6:00 Diagnostic Challenges in the Evaluation of Biliary Strictures Brian Weston, MD

6:15 Advances in the Management of Difficult Biliary Strictures in Interventional Radiology Joshua D. Kuban, MD

6:30 Updates on Personal Cholangioscopy for the Diagnosis and Treatment of Cholangiocarcinoma Jong H. Moon, MD

6:45 Endoscopic Management of Difficult Biliary Strictures of Present and Future Nageshwar Reddy, MD

INTERACTIVE LEARNINGPanelists: Jong H. Moon, MD; Mohamed Othman, MD; Nageshwar Reddy, MD;

Nirav Thosani, MD; Brian Weston, MD

7:00 Difficult Cases I Khushboo Munot, MD

7:20 Difficult Cases II Julie C. Guider, MD

7:40 Difficult Cases III Emmanuel Coronel, MD

8:00 Adjourn

Saturday, December 2, 20177:00 a.m. Registration/Exhibits/Continental Breakfast

7:45 Welcome and Introduction of Mr. Kenneth Sawyer & Ms. Becky Sawyer John R. Stroehlein, MD Jeffrey H. Lee, MD, MPH Manoop Bhutani, MD Boris Blechacz, MD

CHOLANGIOCARCINOMA IIModerators: Sandeep Lahoti, MD; Isaac L. Raijman, MD

8:00 Updates on MD Anderson Experience on Cholangiocarcinoma/Management Algorithm Jeffrey H. Lee, MD, MPH

8:15 Molecular Therapies for Cholangiocarcinoma: Current Experiences and Future Trends Boris Blechacz, MD, PhD

8:30 The Advances in Imaging of Biliary Pancreatic Diseases Eric P. Tamm, MD

8:45 Epidemiology and Management of Cholangiocarcinoma: Thailand Perspective Rungsun Rerknimitr, MD

9:00 Management of cholangiocarcinoma and complex biliary strictures in South Korea: What is the optimal approach for relieving biliary obstruction in unresectable malignant hilar tumor: Endoscopy, PTBD or both? Dong Ki Lee, MD, PhD

9:15 Management of Cholanciocarcinoma and Biliary Strictures at Mayo Clinic Bret T. Petersen, MD

9:30 Biliary Cancer: Changing Treatment Paradigms Milind Javle, MD

9:45 Questions and Answers With Panel

10:00 Break/Exhibits

CHOLANGIOCARCINOMA IIIModerators: Mark F. Catalano, MD; Andrew DuPont, MD

10:30 Technical Do’s and Dont’s During Endoscopic Management of Biliary Strictures Bret T. Petersen, MD

10:45 Recent Development of Metal Stents for Malignant Biliary Obstruction Jong H. Moon, MD

11:00 Advances in Endoscopic RFA for Pancreatobiliary Tumors Nageshwar Reddy, MD

11:15 Advances in the Surgical Management of Cholangiocarcinoma/Transplant Thomas A. Aloia, MD

11:30 Questions and Answers With Panel

Noon Lunch (Provided)

PANCREATIC CANCER/AMPULLARY AND DUODENAL NEOPLASMSModerators: Sushovan Guha, MD, PhD; Robert A. Wolff, MD

1:00 p.m. Comprehensive Updates on Risk Assessment for Pancreatic Cancer, Genetic/Environment Selvi Thirumurthi, MD

1:15 Biomarkers/Controversies and Recommendations in Screening for Pancreatic Adenocarcinoma Manoop Bhutani, MD; Florencia McAllister, MD

1:30 Diagnosis and Management of Pancreaticobiliary Disorders That Mimic Cancer Paul R. Tarnasky, MD

1:45 Drug Eluting Biliary Stents: Where We Are and Where We Need to Go Dong Ki Lee, MD, PhD

2:00 Advances in the Management of Borderline Resectable Pancreatic Cancer Rachna Schroff, MD

2:15 Updates in advances in surgical management of Pancreatic Adenocarcinoma Matthew Katz, MD

2:30 Updates on the Management of Pancreatic Cysts: How to Navigate Through Intricate Guidelines Brian Jacobson, MD

2:45 Updates on the Management of Ampullary and Duodenal Lesions Juergen Hochberger, MD

3:00 Questions and Answers With Panel

3:30 Closing Remarks/Adjourn

MD Anderson Faculty

Thomas A. Aloia, MDHead of the Institute for Cancer CareAssociate ProfessorSurgical Oncology

Manoop Bhutani, MDDirector Honoris CausaWalter B. Wriston Distinguished Professor forPancreatic Cancer ResearchProfessorGastroenterology, Hepatology & Nutrition

Boris Blechacz, MD, PhDAssistant ProfessorGastroenterology, Hepatology & Nutrition

Milind Javle, MDProfessorGI Medical Oncology

Matthew H. G. Katz, MDAssociate ProfessorSurgical Oncology

Joshua D. Kuban, MDAssistant ProfessorVascular and Interventional Radiology

Jeffrey H. Lee, MD, MPHProfessor and DirectorAdvanced Therapeutic Endoscopy FellowshipProfessorGastroenterology, Hepatology & Nutrition

Florencia McAllister, MDAssistant ProfessorClinical Cancer Prevention

Rachna Shroff, MDAssistant ProfessorGI Medical Oncology

John R. Stroehlein, MDProfessor and Chair Ad InterimGastroenterology, Hepatology & Nutrition

Eric P. Tamm, MDProfessorDiagnostic Radiology

Selvi Thirumurthi, MDAssociate ProfessorGastroenterology, Hepatology & Nutrition

Brian Weston, MDAssociate ProfessorGastroenterology, Hepatology & Nutrition

Robert A. Wolff, MDProfessorGI Medical Oncology

Guest Faculty

Juergen Hochberger, MDChief PhysicianVivantes Clinic in Friedrichshain-Landsberger AlleeLandsberger, Berlin, Germany

Brian C. Jacobson, MD, MPHAssociate Director of Endoscopy ProgramAssociate Professor of MedicineBoston University School of MedicineBoston, Massachusetts

Dong Ki Lee, MD, PhDProfessor and DirectorDepartment of Internal MedicineGangnam Severance HospitalYonsei University School of MedicineSeoul, South Korea

Stacie LindseyPresident and FounderCholangiocarcinoma FoundationSalt Lake City, Utah

Jong Ho Moon, MDProfessor of MedicineDirectorDigestive Disease CenterSoon Chun Hyang University School of MedicineBucheo, Seoul, Korea

Bret T. Peterson, MDProfessor of MedicineDivision of Gastrenterology and HepatologyMayo ClinicRochester, Minnesota

Nageshwar Reddy, MDChairmanAsian Institute of GastroenterologySomajiguda, Hyderabad, India

Rungsun Rerknimitr, MDProfessor of MedicineChief, Division of GastroenterologyDirector of GI Endscopy Excellence CenterChulalongkorn UniversityWan, Krung Thep Maha Nakhon, Thailand

Paul R. Tarnasky, MDMedical DirectorMethodist Digestive InstituteProgram DirectorGastroenterology FellowshipDigestive Health Associates of TexasDallas, Texas

Registration Information

On-site registration opens at 5:00 p.m. on Friday, December 1, 2017. The symposium will begin at 5:45 p.m on Friday, December 1, 2017, and adjourn at 3:30 p.m. on Saturday, December 2, 2017. Advance registration is encouraged as space and materials are limited. Please see the registration form for applicable fees.

The full conference registration fee includes the tuition, program syllabus, continental breakfast, breaks, and lunch.

The deadline for advance registration is Friday, November 10, 2017.

There are three ways to register:1. On-line at www.mdanderson.org/conferences2. Fax to: 713-794-17243. Mail to: CME/Conference Management

Unit 1781 The University of Texas MD Anderson Cancer Center P.O. Box 301407 Houston, TX 77230-1407

When registering online a confirmation letter will be automatically e-mailed to the e-mail address you list on the registration form. If you register by fax or mail, a receipt/confirmation letter will be sent to you within ten working days of receipt of your registration.

The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee.

The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

Special Assistance

Contact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

Accommodations

• A block of rooms has been reserved for conference attendees at the Houston Marriott Medical Center, 6580 Fannin Street, Houston, Texas.

Moderators

Mark F. Catalano, MDProfessor of MedicineUniversity of Texas, McGovern Medical SchoolChief of Endoscopy MHSECo-Director of Advanced Endoscopy Fellowship ProgramUT Health Science CenterHouston, Texas

Andrew Dupont, MDAssociate ProfessorGastroenterology/Hepatology and NutritionUT Health Science Center at HoustonHouston, Texas

Sushovan Guha, MD, PhDAssociate ProfessorAssociate DirectorDivision of Gastroenterology, Hepatology and NutritionAssociate Director GI Fellowship ProgramUT Health Science CenterHouston, Texas

Sandeep Lahoti, MDAssociate Chief for Clinical AffairsHouston Methodist Gastroenterology ConsultantsHouston, Texas

Gottumukkala S. Raju, MDJohn Stroehlein Distinguished ProfessorGastroenterology, Hepatology & NutritionMD AndersonHouston, Texas

Isaac L. Raijman, MDClinical Associate Professor of MedicineBaylor College of MedicineClinical Associate Professor of MedicineTexas Health Science CenterCo-FounderGreater Houston GastroenterologyHouston, Texas

Panelists

Mohamed Othman, MDTitleBaylor St. Luke’s Medical CenterHouston, Texas

Nirav Thosani, MDAssistant ProfessorUT Health Science CenterHouston, Texas

Advanced Fellows

Emmanuel Coronel, MDMD AndersonHouston, Texas

Julie C. Guider, MDUT Health Science CenterHouston, Texas

Khushboo Mumot, MDBaylor College of MedicineHouston, Texas

• Early hotel reservation is suggested. To make reservations, please call Reservations at 713-796-0080 and identify yourself as part of the MD Anderson 2nd Sawyer International Pancreatobiliary Symposium.

• The special meeting rate is $99.00 single or double occupancy. Please add 17% Texas State and local taxes. Reservations and deposits received after November 10, 2017 will be confirmed if space is available and at current hotel published guest room rates.

Ground Transportation

• Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU).

• Taxicabs are available at an estimated cost for $50-60, to or from William P. Hobby Airport or George Bush Intercontinental Airport.

• Super Shuttle operates a shuttle bus between George Bush Intercontinental Airport and the Houston Marriott Medical Center for $27 one-way and $54 round-trip. For more information, call 713-523-8888 or toll-free at 800-258-3826 or on-line at www.supershuttle.com.

• Super Shuttle operates a shuttle bus between William P. Hobby Airport and the Houston Marriott Medical Center for $24 one-way and $48 round-trip. For more information, call 713-523-8888 or toll-free at 800-258-3826 or on-line at www.supershuttle.com.

Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration.

CO

NFE

REN

CE

REG

ISTR

ATI

ON

- 176

700/

30/1

1720

8/41

MD

Ande

rson

– 2

nd A

nnua

l Saw

yer I

nter

natio

nal P

ancr

eato

bilia

ry S

ympo

sium

De

cem

ber 1

-2, 2

017

THIS

IS N

OT A

SEL

F-M

AILE

R - A

ddre

ss to

: M

D An

ders

on –

2nd

Ann

ual S

awye

r Int

erna

tiona

l Pa

ncre

atob

iliar

y Sy

mpo

sium

Dece

mbe

r 1-2

, 201

7De

partm

ent o

f CM

E/Co

nfer

ence

Man

agem

ent –

Uni

t 178

1Th

e Un

ivers

ity o

f Tex

as M

D An

ders

on C

ance

r Cen

ter

PO B

ox 3

0140

7, H

oust

on, T

X 77

230-

1407

or fa

x to

713-

794-

1724

M

ake

chec

k or m

oney

ord

er p

ayab

le to

: Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r

Regi

stra

tion

Fees

1Ph

ysic

ians

. . .

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

. .$5

0 .00

1St

uden

ts . .

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

. . . .

. .$2

5 .00

__ I

wou

ld li

ke to

app

ly fo

r the

Dr .

Raju

-Joh

n St

roeh

lein

Dis

tingu

ishe

d Pr

ofes

sors

hip

Scho

lars

hip

Last

Nam

eFi

rst

MI

High

est D

egre

e

Depa

rtmen

t (in

clud

e un

it no

.) Sp

ecia

lty

Inst

itutio

n

MD

Ande

rson

Em

ploy

ee ID

No.

(req

uire

d fo

r all

MDA

CC e

mpl

oyee

s):

Phys

icia

n Y

es

N

o

Stre

et

City

Stat

e/Fo

reig

n Co

untry

/Zip

or M

ail C

ode

Dayt

ime

Phon

e (w

ith a

rea

code

) Ce

ll Ph

one

(with

are

a co

de)

Fax

(with

are

a co

de)

E-m

ail A

ddre

ss (p

leas

e pr

int)

Emer

genc

y Co

ntac

tPh

one

(with

are

a co

de)

Cred

it Ca

rd H

olde

r Nam

e (F

irst/

Last

) Ch

arge

the

follo

win

g: V

ISA

M

C

AM

EX

Cred

it Ca

rd N

umbe

rEx

pira

tion

Date

Secu

rity

Code

/CVV

/CSV

Cred

it Ca

rd H

olde

r Bill

ing

Addr

ess

& Z

IP C

ode

MD

And

erso

n In

terd

epar

tmen

tal T

rans

fer (

IDT)

No .

: *Fu

nd G

roup

90

will

not

be

acce

pted

Bus

ines

s U

nit

Dep

artm

ent

Fund

Gro

up*

Fund

Fund

Typ

e

Aut

hori

zed

Sign

atur

e RE

QU

IRED

for C

RED

IT C

ARD

or I

DT

IDT

Appr

over

Nam

e (F

irst/L

ast)

plea

se p

rint

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.

Photographing, audio taping and videotaping are prohibited.

Depa

rtmen

t of C

ME/

Conf

eren

ce M

anag

emen

t- Un

it 17

81Th

e Un

iver

sity

of T

exas

MD

Ande

rson

Can

cer C

ente

r17

6700

/30/

1172

08/4

1PO

Box

301

407

Hous

ton,

TX

7723

0-14

07

Non

-Pro

fit O

rg.

U.S.

Pos

tage

P A

I DHo

usto

n, T

XPe

rmit

No.

705

2